KARBINAL ER Drug Patent Profile

✉ Email this page to a colleague

When do Karbinal Er patents expire, and what generic alternatives are available?

Karbinal Er is a drug marketed by Aytu and is included in one NDA. There are two patents protecting this drug.

This drug has twenty-one patent family members in fourteen countries.

The generic ingredient in KARBINAL ER is carbinoxamine maleate. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the carbinoxamine maleate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Karbinal Er

A generic version of KARBINAL ER was approved as carbinoxamine maleate by GENUS on March 19^th, 2003.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for KARBINAL ER?
What are the global sales for KARBINAL ER?
What is Average Wholesale Price for KARBINAL ER?

Summary for KARBINAL ER

International Patents:	21
US Patents:	2
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	62
Patent Applications:	1,287
Drug Prices:	Drug price information for KARBINAL ER
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for KARBINAL ER
DailyMed Link:	KARBINAL ER at DailyMed

Drug patent expirations by year for KARBINAL ER

Pharmacology for KARBINAL ER

Drug Class	Histamine-1 Receptor Antagonist
Mechanism of Action	Histamine H1 Receptor Antagonists

US Patents and Regulatory Information for KARBINAL ER

KARBINAL ER is protected by two US patents.

Patents protecting KARBINAL ER

Modified release formulations containing drug-ion exchange resin complexes
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Modified release formulations containing drug--ion exchange resin complexes
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aytu	KARBINAL ER	carbinoxamine maleate	SUSPENSION, EXTENDED RELEASE;ORAL	022556-001	Mar 28, 2013		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Aytu	KARBINAL ER	carbinoxamine maleate	SUSPENSION, EXTENDED RELEASE;ORAL	022556-001	Mar 28, 2013		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for KARBINAL ER

See the table below for patents covering KARBINAL ER around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
China	102488652	Modified release formulations containing drug-ion exchange resin complexes	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2007109104		⤷ Sign Up
Taiwan	200812649	Modified release formulations containing drug-ion exchange resin complexes	⤷ Sign Up
Russian Federation	2435569	КОМПОЗИЦИИ С МОДИФИЦИРОВАННЫМ ВЫСВОБОЖДЕНИЕМ, СОДЕРЖАЩИЕ КОМПЛЕКСЫ ЛЕКАРСТВЕННОЕ ВЕЩЕСТВО - ИОНООБМЕННАЯ СМОЛА (COMPOSITIONS WITH MODIFIED RELEASE, CONTAINING COMPLEXES MEDICATION-ION-EXCHANGING RESIN)	⤷ Sign Up
European Patent Office	2428205	Formulations à libération modifiée contenant des complexes médicament - résine échangeuse d'ions (Modified release formulations containing drug-ion exchange resin complexes)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for KARBINAL ER

Pharmacology for KARBINAL ER

Patents protecting KARBINAL ER

Make Better Decisions: Try a trial or see plans & pricing